Tag Archive for: drug repurposing
Repurposing FDA-Approved Drugs for PIM-1 Kinase Inhibition: A Potential Avenue for Prostate Cancer
/0 Comments/in Drug repurposing, Preclinical Research/by MaxMetformin Shows Promise in Reducing Side Effects of Hormone Therapy in Advanced Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 3/by MaxTags
abiraterone acetate ADT ai in healthcare alphafold AMG 509 androgen deprivation therapy antibody-drug conjugate apalutamide ARANOTE ATM bispecific antibody bone metastases BRCA2 cancer immunotherapy cancer treatment castration-resistant prostate cancer chemotherapy clinical trial clinical trials crispr darolutamide docetaxel drug discovery drug repurposing drug resistance enzalutamide hormone therapy immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC neuroendocrine prostate cancer oncology oncolytic virus PARP inhibitor personalized medicine preclinical prostate cancer PSMA radioligand therapy radiopharmaceuticals STEAP1 T-cell therapy theranostics
Latest Posts
- Repurposing Antipsychotic Drugs: Potential New Cancer Treatments January 22, 2025
- We can’t always win: LAVA-1207 Development Discontinued, Not Related to Safety Issues January 21, 2025
- Newsletter 3/2025 January 19, 2025
- PARP Inhibitors in Prostate Cancer: Navigating the Complexities of DNA Repair January 18, 2025